Pediatric Growth Hormone Dosing Frequency
Growth hormone (somatropin) therapy in children is recommended as daily dosing (typically 6 to 7 injections per week) rather than every-other-day dosing. [1]
Every-other-day dosing is not a standard recommendation in contemporary pediatric growth hormone deficiency guidance. [1]
Medication Selection Algorithm
Recombinant human growth hormone dosing should be individualized by diagnosis and weight-based or body surface area–based dosing strategy. [1]
An initial dose of 0.16 to 0.24 mg/kg/week (22 to 35 μg/kg/day) is recommended for growth hormone deficiency with subsequent titration to response. [1]
Key Evidence Supporting This Recommendation
Clinical studies of growth in children treated with growth hormone have used dosing 6 to 7 days per week in the majority of cases. [1]
Thrice-weekly dosing has shown lower growth outcomes than daily dosing when comparing equivalent weekly dosing schedules. [1]
Monotherapy vs Combination Therapy
Growth hormone dosing frequency decisions apply to monotherapy dosing schedules. [1]
Combination therapy is not a basis for converting to every-other-day injections. [1]
Important Clarifications or Nuances
The pediatric endocrinology consensus notes that historical less-frequent regimens (such as thrice-weekly) were used after recombinant growth hormone introduction and that evidence supports daily rather than thrice-weekly frequency for height outcomes. [1]
The evidence base supporting every-other-day somatropin administration in a 6-year-old is not presented in the pediatric consensus guidance. [1]
Treatment Initiation Thresholds
Initiation thresholds depend on the underlying diagnosis and growth hormone deficiency assessment rather than dosing frequency selection. [1]
Common Pitfalls to Avoid
Using a less frequent regimen than the dosing frequency used in the majority of published pediatric growth outcomes may reduce linear growth response. [1]
Adopting every-other-day dosing without guideline support risks subtherapeutic exposure compared with recommended daily dosing schedules. [1]
Targets or Goals of Therapy
Dose titration is guided by growth response and typically uses serum insulin-like growth factor 1 (IGF-1) during follow-up to optimize treatment effect. [1]